Clinical Development of the Next Wave of mRNA-Based Vaccines To Tackle Global Infectious Diseases & Future Pandemics
2.00 Moving Towards a “Best-in-Class” Platform for mRNA-Based
Vaccines & Beyond
Download the full event guide for full details.
Joshua DiNapoli, Global Project Head - mRNA Platform Development, Sanofi Pasteur
2.30 New LNP Manufacturing Strategies to Accelerate mRNA Vaccine Development
Download the full event guide for full details.
Jason Coleman, Clinical Application Scientist Lead
Precision NanoSystems , Precision NanoSystems
3.00 Next Generation Self-Replicating RNA Enable Next Wave of Complex Infectious Disease Vaccines
Download the full event guide for full details.
Nathaniel Wang, CEO & Co-Founder, Replicate Bioscience
3.30 Developing Next Generation mRNA Vaccines using Ligand-Directed Targeting to Immune Cells
Download the full event guide for full details.
Daryl Drummond, CSO & Co-Founder, Akagera Medicines